Cargando…

Intraductal Papillary Mucinous Neoplasm of Pancreas

Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are neoplasms that are characterized by ductal dilation, intraductal papillary growth, and thick mucus secretion. This relatively recently defined pathology is evolving in terms of its etiopathogenesis, clinical features, diagnosis, ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Machado, Norman Oneil, al Qadhi, Hani, al Wahibi, Khalifa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462811/
https://www.ncbi.nlm.nih.gov/pubmed/26110127
http://dx.doi.org/10.4103/1947-2714.157477
_version_ 1782375713148502016
author Machado, Norman Oneil
al Qadhi, Hani
al Wahibi, Khalifa
author_facet Machado, Norman Oneil
al Qadhi, Hani
al Wahibi, Khalifa
author_sort Machado, Norman Oneil
collection PubMed
description Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are neoplasms that are characterized by ductal dilation, intraductal papillary growth, and thick mucus secretion. This relatively recently defined pathology is evolving in terms of its etiopathogenesis, clinical features, diagnosis, management, and treatment guidelines. A PubMed database search was performed. All the relevant abstracts in English language were reviewed and the articles in which cases of IPMN could be identified were further scrutinized. Information of IPMN was derived, and duplication of information in several articles and those with areas of persisting uncertainties were excluded. The recent consensus guidelines were examined. The reported incidence of malignancy varies from 57% to 92% in the main duct-IPMN (MD-IPMN) and from 6% to 46% in the branch duct-IPMN (BD-IPMN). The features of high-risk malignant lesions that raise concern include obstructive jaundice in a patient with a cystic lesion in the pancreatic head, the findings on radiological imaging of a mass lesion of >30 mm, enhanced solid component, and the main pancreatic duct (MPD) of size ≥10 mm; while duct size 5-9 mm and cyst size <3 mm are considered as “worrisome features.” Magnetic resonance imaging (MRI) and endoscopic ultrasound (EUS) are primary investigations in diagnosing and following up on these patients. The role of pancreatoscopy and the analysis of aspirated cystic fluid for cytology and DNA analysis is still to be established. In general, resection is recommended for most MD-IPMN, mixed variant, and symptomatic BD-IPMN. The 5-year survival of patients after surgical resection for noninvasive IPMN is reported to be at 77-100%, while for those with invasive carcinoma, it is significantly lower at 27-60%. The follow-up of these patients could vary from 6 months to 1 year and would depend on the risk stratification for invasive malignancy and the pathology of the resected specimen. The understanding of IPMN has evolved over the years. The recent guidelines have played a role in this regard.
format Online
Article
Text
id pubmed-4462811
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-44628112015-06-24 Intraductal Papillary Mucinous Neoplasm of Pancreas Machado, Norman Oneil al Qadhi, Hani al Wahibi, Khalifa N Am J Med Sci Review Article Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are neoplasms that are characterized by ductal dilation, intraductal papillary growth, and thick mucus secretion. This relatively recently defined pathology is evolving in terms of its etiopathogenesis, clinical features, diagnosis, management, and treatment guidelines. A PubMed database search was performed. All the relevant abstracts in English language were reviewed and the articles in which cases of IPMN could be identified were further scrutinized. Information of IPMN was derived, and duplication of information in several articles and those with areas of persisting uncertainties were excluded. The recent consensus guidelines were examined. The reported incidence of malignancy varies from 57% to 92% in the main duct-IPMN (MD-IPMN) and from 6% to 46% in the branch duct-IPMN (BD-IPMN). The features of high-risk malignant lesions that raise concern include obstructive jaundice in a patient with a cystic lesion in the pancreatic head, the findings on radiological imaging of a mass lesion of >30 mm, enhanced solid component, and the main pancreatic duct (MPD) of size ≥10 mm; while duct size 5-9 mm and cyst size <3 mm are considered as “worrisome features.” Magnetic resonance imaging (MRI) and endoscopic ultrasound (EUS) are primary investigations in diagnosing and following up on these patients. The role of pancreatoscopy and the analysis of aspirated cystic fluid for cytology and DNA analysis is still to be established. In general, resection is recommended for most MD-IPMN, mixed variant, and symptomatic BD-IPMN. The 5-year survival of patients after surgical resection for noninvasive IPMN is reported to be at 77-100%, while for those with invasive carcinoma, it is significantly lower at 27-60%. The follow-up of these patients could vary from 6 months to 1 year and would depend on the risk stratification for invasive malignancy and the pathology of the resected specimen. The understanding of IPMN has evolved over the years. The recent guidelines have played a role in this regard. Medknow Publications & Media Pvt Ltd 2015-05 /pmc/articles/PMC4462811/ /pubmed/26110127 http://dx.doi.org/10.4103/1947-2714.157477 Text en Copyright: © North American Journal of Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Machado, Norman Oneil
al Qadhi, Hani
al Wahibi, Khalifa
Intraductal Papillary Mucinous Neoplasm of Pancreas
title Intraductal Papillary Mucinous Neoplasm of Pancreas
title_full Intraductal Papillary Mucinous Neoplasm of Pancreas
title_fullStr Intraductal Papillary Mucinous Neoplasm of Pancreas
title_full_unstemmed Intraductal Papillary Mucinous Neoplasm of Pancreas
title_short Intraductal Papillary Mucinous Neoplasm of Pancreas
title_sort intraductal papillary mucinous neoplasm of pancreas
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462811/
https://www.ncbi.nlm.nih.gov/pubmed/26110127
http://dx.doi.org/10.4103/1947-2714.157477
work_keys_str_mv AT machadonormanoneil intraductalpapillarymucinousneoplasmofpancreas
AT alqadhihani intraductalpapillarymucinousneoplasmofpancreas
AT alwahibikhalifa intraductalpapillarymucinousneoplasmofpancreas